NL8020152A - Werkwijze ter bereiding van sterk gezuiverde protrom- bine-complexconcentraten, de aldus verkregen concen- traten en hun toepassing. - Google Patents

Werkwijze ter bereiding van sterk gezuiverde protrom- bine-complexconcentraten, de aldus verkregen concen- traten en hun toepassing. Download PDF

Info

Publication number
NL8020152A
NL8020152A NL8020152A NL8020152A NL8020152A NL 8020152 A NL8020152 A NL 8020152A NL 8020152 A NL8020152 A NL 8020152A NL 8020152 A NL8020152 A NL 8020152A NL 8020152 A NL8020152 A NL 8020152A
Authority
NL
Netherlands
Prior art keywords
prothrombin complex
source
process according
iii
elution
Prior art date
Application number
NL8020152A
Other languages
English (en)
Dutch (nl)
Original Assignee
Merieux Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merieux Inst filed Critical Merieux Inst
Publication of NL8020152A publication Critical patent/NL8020152A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8020152A 1979-05-04 1980-05-05 Werkwijze ter bereiding van sterk gezuiverde protrom- bine-complexconcentraten, de aldus verkregen concen- traten en hun toepassing. NL8020152A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7911272 1979-05-04
FR7911272A FR2472390A1 (fr) 1979-05-04 1979-05-04 Procede de preparation de concentres de complexe prothrombinique hautement purifies, et concentres obtenus

Publications (1)

Publication Number Publication Date
NL8020152A true NL8020152A (nl) 1981-02-27

Family

ID=9225039

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8020152A NL8020152A (nl) 1979-05-04 1980-05-05 Werkwijze ter bereiding van sterk gezuiverde protrom- bine-complexconcentraten, de aldus verkregen concen- traten en hun toepassing.

Country Status (18)

Country Link
US (1) US4465623A (de)
JP (1) JPH0424360B2 (de)
AR (1) AR227021A1 (de)
AT (1) ATA903980A (de)
BE (1) BE883096A (de)
CA (1) CA1157375A (de)
CH (1) CH654329A5 (de)
DE (1) DE3043409C3 (de)
DK (1) DK157169C (de)
ES (1) ES491042A0 (de)
FR (1) FR2472390A1 (de)
GB (1) GB2061287B (de)
IT (1) IT1131109B (de)
MX (1) MX5960E (de)
NL (1) NL8020152A (de)
NO (1) NO155477C (de)
SE (1) SE452250C (de)
WO (1) WO1980002426A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663164A (en) * 1980-01-28 1987-05-05 Baxter Travenol Laboratories, Inc. Aqueous compositions for treating blood clotting factor inhibitors
EP0044343B1 (de) * 1980-01-28 1984-08-22 Baxter Travenol Laboratories, Inc. Prothrombin enthaltende therapeutische zusammensetzungen und verfahren zur herstellung enzymatisch aktiver blutgerinnungsfaktoren aus prothrombin enthaltenden blutfraktionen
AT379310B (de) * 1983-05-20 1985-12-27 Immuno Ag Verfahren zur herstellung eines antithrombin iii-heparin- bzw. antithrombin iii-heparinoidkonzentrates
US4786726A (en) * 1986-01-06 1988-11-22 Blood Systems, Inc. Factor IX therapeutic blood product, means and methods of preparing same
DE3622642A1 (de) * 1986-07-05 1988-01-14 Behringwerke Ag Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
DE3727610A1 (de) * 1987-08-19 1989-03-02 Behringwerke Ag Synthetische peptide, gegen diese gerichtete antikoerper und deren verwendung
US6541275B1 (en) 1988-02-03 2003-04-01 Dade Behring Inc. Immunoassay for F1.2 prothrombin fragment
JPH0219400A (ja) * 1988-07-07 1990-01-23 Green Cross Corp:The トロンビンまたはプロトロンビンの製造方法
KR100330540B1 (ko) * 1993-04-05 2002-09-04 웰파이드 코포레이션 안티트롬빈-iii액상제제및그안정화방법
US6562781B1 (en) 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US7045585B2 (en) * 1995-11-30 2006-05-16 Hamilton Civic Hospital Research Development Inc. Methods of coating a device using anti-thrombin heparin
US6491965B1 (en) 1995-11-30 2002-12-10 Hamilton Civic Hospitals Research Development, Inc. Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US20080306610A1 (en) * 2007-06-07 2008-12-11 Zimmer Orthobiologics, Inc. Tissue processing for nonimmunogenic implants
US8435305B2 (en) 2010-08-31 2013-05-07 Zimmer, Inc. Osteochondral graft delivery device and uses thereof
USD850006S1 (en) 2017-11-27 2019-05-28 Mary Kay Inc. Cosmetic compact
USD843660S1 (en) 2017-11-27 2019-03-19 Mary Kay Inc. Cosmetic compact
USD863685S1 (en) 2017-11-27 2019-10-15 Mary Kay Inc. Cosmetic compact

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2867567A (en) * 1955-01-21 1959-01-06 Nat Res Dev Process of preparing anti-haemophilic globulin
US3560475A (en) * 1969-06-19 1971-02-02 Baxter Laboratories Inc Prothrombin complex prepared by precipitation with polyethylene glycol
JPS5314604B2 (de) * 1972-12-20 1978-05-18
US4087415A (en) * 1976-06-09 1978-05-02 William L. Wilson Antithrombin III
US4081432A (en) * 1977-07-25 1978-03-28 Monsanto Company Method of separating a Factor IX preparation from plasma using ethylene-maleic anhydride polymers
JPS6040859B2 (ja) * 1977-07-27 1985-09-12 喜温 三浦 抗血栓性人工医療材料
AT359646B (de) * 1979-04-19 1980-11-25 Immuno Ag Verfahren zur herstellung von nebenwirkungs- freien plasmafraktionen
DE3101752A1 (de) * 1981-01-21 1982-08-26 Behringwerke Ag, 3550 Marburg "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen"

Also Published As

Publication number Publication date
NO155477B (no) 1986-12-29
FR2472390A1 (fr) 1981-07-03
NO810009L (no) 1981-01-02
DK157169C (da) 1990-04-23
ES8100763A1 (es) 1980-12-01
AR227021A1 (es) 1982-09-15
IT1131109B (it) 1986-06-18
DE3043409T1 (de) 1982-02-18
CA1157375A (fr) 1983-11-22
WO1980002426A1 (fr) 1980-11-13
JPS56500569A (de) 1981-04-30
IT8021723A0 (it) 1980-05-02
US4465623A (en) 1984-08-14
ES491042A0 (es) 1980-12-01
SE452250B (sv) 1987-11-23
DK1281A (da) 1981-01-02
GB2061287B (en) 1983-09-14
SE8009157L (sv) 1980-12-29
ATA903980A (de) 1982-05-15
SE452250C (sv) 1998-03-20
FR2472390B1 (de) 1983-07-08
GB2061287A (en) 1981-05-13
BE883096A (fr) 1980-11-03
DE3043409C2 (de) 1993-12-23
JPH0424360B2 (de) 1992-04-24
MX5960E (es) 1984-09-06
DE3043409C3 (de) 1993-12-23
NO155477C (no) 1987-04-08
CH654329A5 (fr) 1986-02-14
DK157169B (da) 1989-11-20

Similar Documents

Publication Publication Date Title
NL8020152A (nl) Werkwijze ter bereiding van sterk gezuiverde protrom- bine-complexconcentraten, de aldus verkregen concen- traten en hun toepassing.
CA2201714C (en) Method for isolation of highly pure von willebrand factor
US7498146B2 (en) Stable factor VIII/von willebrand factor complex
DK173859B1 (da) Fremgangsmåde til fremstilling af et højrenset humant faktor IX koncentrat og andre plasmaproteiner
US5099003A (en) Method of preparing a sterile plasma-protein solution containing fibrinogen and factor xiii
AU737986B2 (en) Purification of von willebrand factor by cation exchange chromatography
ES2281104T3 (es) Proceso para separar el inhibidor de alfa-1-proteinasa de una pasta de fraccion cohn iv-1 + iv-4.
JPH10509144A (ja) ▲ｖｉｉｉ▼因子の精製方法
DK162233B (da) Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii
US6579723B1 (en) Method of recovering highly purified vWF or factor VIII/vWF-complex
EP0148843B1 (de) Antihämophilie-faktor-viii-konzentrat und dessen herstellungsverfahren
US5097019A (en) Pharmaceutical containing tissue protein pp4, a process for the preparation of pp4 and for the pasteurization thereof, and the use of pp4
US5252217A (en) Blood coagulation factor XI concentrate having high specific activity, suitable for therapeutic use, and process for preparing same
US4774323A (en) Purification of von Willebrand Factor solutions using gel permeation chromatography
AU2003248466B2 (en) Concentrate of a factor VIII:C-containing von Willebrand factor and the process relating thereto
KR20000036002A (ko) 혈장 단백질 함유 약제를 제조하는 방법
Wickerhauser et al. Development of Large-Scale Fractionation Methods
JPS59167519A (ja) 不活化トロンビンゲルにより血漿タンパク質混合液からフイブリノ−ゲンを除去する方法
Smith et al. Advances in Plasma Fractionation and in the Production of Factor VIII Concentrates
EP0126789B1 (de) Antihaemophilisches Faktorkonzentrat und Verfahren zur Herstellung
JPS61207334A (ja) 腫瘍細胞障害性物質

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BN A decision not to publish the application has become irrevocable